Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...
Preclinical data showed GB3226's superior efficacy to both FLT3 and menin inhibitors in animal models, as well as ... trial of GB1211 in combination with pembrolizumab (Keytruda®) in metastatic ...
Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a ...
Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.
Telomir Pharmaceuticals (TELO) announced on Wednesday preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate ca ...
Interim analysis findings showed the perioperative treatment group demonstrated a statistically significant improvement in event-free survival compared with adjuvant radiotherapy, with or without ...
While animal models are critical for understanding disease mechanisms and testing therapeutic approaches, they do not always fully mimic the human condition. For ALS, for example, even the best ...
MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy
Macbecin II was identified as a compound that upregulates MHC-I expression, enhancing immune-mediated cancer cell killing. In ...
A Tesla executive has announced that the automaker plans to update its Model S and Model X vehicle programs later this year. In 2021, Tesla introduced updated versions of the Model S and Model X ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results